An update to the American Radium Society’s appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors
Tom M, Nagpal S, Palmer J, Breen W, Pollom E, Lehrer E, McGranahan T, Shiue K, Chundury A, McClelland Iii S, Saeed H, Chang E, Chiang V, Wang T, Knisely J, Chao S, Milano M. An update to the American Radium Society’s appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiotherapy And Oncology 2024, 202: 110640. PMID: 39557126, DOI: 10.1016/j.radonc.2024.110640.Peer-Reviewed Original Research